10-Q: TILT Holdings Reports Q2 Loss Amid Revenue Decline

TILT Holdings Inc. reported a significant net loss and revenue decline for the second quarter and first half of 2025, alongside ongoing liquidity concerns and legal challenges.

Summary

• Net loss for the six months ended June 30, 2025, was $25,302 thousand, an improvement from $45,598 thousand in the prior year, primarily due to decreased income tax expense and operating expenses.
• Revenue for the six months ended June 30, 2025, decreased by 44% to $27,417 thousand from $48,910 thousand in the same period last year, mainly driven by a 49% decline in Jupiter's revenue.
• Gross profit for the six months ended June 30, 2025, was $4,840 thousand, a 46% decrease from $9,008 thousand in the prior year, though gross margin remained stable at 18%.
• Operating expenses decreased by 25% to $14,395 thousand for the six months ended June 30, 2025, due to cost reduction strategies, including reduced headcount and third-party services.
• Interest expense increased by 36% to $13,698 thousand for the six months ended June 30, 2025, primarily due to compounding interest on certain debt and the 2024 Standard Farms Loan.
• The company had negative working capital of $93,881 thousand as of June 30, 2025, worsening from $46,627 thousand as of December 31, 2024.
• Cash and cash equivalents decreased to $772 thousand as of June 30, 2025, from $1,643 thousand as of December 31, 2024.
• Cash provided by operating activities from continuing operations significantly improved to $4,385 thousand for the six months ended June 30, 2025, compared to cash used of $2,117 thousand in the prior year, largely due to IRS Employee Retention Credit (ERC) refunds.
• The company is divesting its plant-touching assets, with the sale of Massachusetts dispensaries (Retail Disposal Group) expected to be completed within 12 months for $2,000 thousand plus assumed liabilities.
• Wholesale-related operations in Massachusetts and Ohio (Wholesale Disposal Group) have been classified as held for sale.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, evidenced by significant revenue decline, worsening negative working capital, high default interest rates on substantial debt, and a 'going concern' warning from management. While cost reduction efforts and IRS refunds provided some relief, the overall financial health and outlook remain highly precarious, compounded by ongoing litigation and regulatory uncertainty.

Positives

• Net loss from continuing operations decreased by 21% to $18,413 thousand for the six months ended June 30, 2025, compared to $23,209 thousand in the prior year.
• Net loss from discontinued operations improved significantly by 69% to $6,889 thousand for the six months ended June 30, 2025, from $22,389 thousand in the prior year.
• Total operating expenses decreased by 25% due to successful cost reduction strategies, including reduced headcount and third-party services.
• Cash provided by operating activities from continuing operations was $4,385 thousand for the six months ended June 30, 2025, a substantial improvement from cash used of $2,117 thousand in the prior year, driven by IRS ERC refunds.
• The company recognized a gain of $1,160 thousand on the termination of a lease related to the closure of its former Cambridge, Massachusetts dispensary.

Negatives

• Revenue for the six months ended June 30, 2025, decreased by 44% year-over-year, primarily due to a 49% decline in Jupiter's sales volume.
• Gross profit decreased by 46% for the six months ended June 30, 2025, mainly due to decreased sales volume at Jupiter and price compression in the cannabis division.
• Negative working capital worsened significantly to $93,881 thousand as of June 30, 2025, from $46,627 thousand as of December 31, 2024.
• Cash and cash equivalents declined to $772 thousand as of June 30, 2025, from $1,643 thousand at year-end 2024.
• Notes payable (current portion) increased substantially to $66,542 thousand as of June 30, 2025, from $28,336 thousand as of December 31, 2024.
• Interest expense increased by 36% for the six months ended June 30, 2025, due to compounding interest on certain debt and the 2024 Standard Farms Loan.
• The company is not in compliance with certain payment obligations and covenants under its 2023 Refinanced Notes and 2023 New Notes, leading to default interest rates of 25.0% and 24.0% respectively.
• Management has concluded there is substantial doubt about the company's ability to continue as a going concern within 12 months.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern within 12 months, potentially leading to liquidation or loss of investment for shareholders.
• Inability to achieve financial projections or raise additional capital could reduce competitiveness and negatively affect the business.
• Default interest rates (25.0% and 24.0%) on significant debt obligations (2023 Refinanced Notes and 2023 New Notes) will constrain liquidity.
• Ongoing negotiations with noteholders regarding non-compliance with payment obligations and covenants may not result in a mutually agreeable resolution.
• Potential for significant dilution of ownership interests if additional equity financing is pursued, as current debt requires proceeds to be paid to debtholders.
• Adverse macroeconomic developments, including inflation, slowing economic growth, rising interest rates, or recession, may hinder access to capital.
• Exposure to multiple class-action antitrust lawsuits alleging violations related to the sale and distribution of closed cannabis oil vaporizing systems, with unspecified damages sought.
• The cannabis industry's status as a controlled substance under U.S. Federal Controlled Substances Act and related enforcement risks.
• Risks related to regulatory or political changes, including uncertainty surrounding existing protection from U.S. federal prosecution relating to cannabis laws.
• Dependency on skilled labor, equipment, parts, components, and key inputs, as well as reliance on third-party suppliers.
• Potential for changes in laws, regulations, and guidelines that could adversely affect future business.
• Risks related to indebtedness and the ability to extend, refinance, or repay such indebtedness.
• Volatility in the market price of the company's securities and potential for dilution.

Future Outlook

Management's operating plans for the next 12 months include increasing revenue growth from existing and new products, reducing production and operational costs through efficiencies and divestitures, reducing supply chain costs, and delaying certain overhead expenditures. The company also plans to obtain additional financing or complete strategic transactions as necessary and defer principal and interest payments on notes payable. However, the company cannot predict with certainty the outcome of these actions or the availability of additional financing, leading to substantial doubt about its ability to continue as a going concern.

Management Comments

• Management believes that successfully implementing operating plans will help mitigate substantial doubt raised by historical operating results and satisfy estimated liquidity needs for the next 12 months.
• Management has concluded there is substantial doubt about the company's ability to continue as a going concern within 12 months after the date of this filing.

Industry Context

The company operates in the global cannabis industry, providing business solutions, technology, hardware, cultivation, and production. The cannabis division faces price compression, while the inhalation technology division (Jupiter) experienced significant revenue decline due to a temporary transition of certain customers to a direct invoicing model with its primary supplier. The industry continues to grapple with the status of cannabis as a controlled substance under U.S. federal law, with the rescheduling process indefinitely delayed, impacting tax treatment (Section 280E) and regulatory clarity.

Comparison to Industry Standards

• The company's gross margin of 18% for the six months ended June 30, 2025, is stable compared to the prior year, but the significant revenue decline in its Jupiter segment (49% year-over-year) due to customer invoicing model changes suggests a unique challenge not necessarily reflective of broader industry trends, but rather a specific operational shift.
• The cannabis division's revenue decrease (8% year-over-year) driven by price compression aligns with a common trend in mature cannabis markets where increased competition and supply can lead to downward pressure on prices, similar to what has been observed in other U.S. state markets like California or Colorado.
• The company's substantial negative working capital ($93,881 thousand) and ongoing non-compliance with debt covenants, leading to high default interest rates (24-25%), indicate a financial position significantly weaker than well-capitalized industry peers or those with more stable revenue streams and access to traditional financing.
• The strategic divestiture of plant-touching assets is a trend seen in some multi-state operators (MSOs) seeking to streamline operations or focus on specific segments, but the company's 'going concern' warning suggests this is driven by financial distress rather than purely strategic optimization, unlike more robust MSOs that might divest for growth capital.

Management Changes

Legal Proceedings

• Multiple class-action antitrust complaints filed against Jupiter (a wholly-owned subsidiary) and other defendants in various U.S. District Courts (Northern District of California, District of Nevada, District of Arizona, Northern District of Illinois, Southern District of Florida).
• Plaintiffs allege violations of federal and state antitrust statutes through the sale and distribution of closed cannabis oil vaporizing systems.
• Cases include S.K., D.C., D.G. (Indirect Named Plaintiffs), Earths Healing Inc., Redbud Roots Inc., Summit Industrial Solutions LLC (Direct Named Plaintiffs), M.M., H.H., B.Z., and Martin Rukeyser.
• Direct purchaser cases have been consolidated, and the S.K. indirect purchaser case has been related to them.
• Defendants (including Jupiter) have filed motions to dismiss the complaints.
• The company is not in a position to assess the likelihood or estimate the amount of potential loss from these actions.

Related Party Transactions

• Refinanced a payable due to Mark Scatterday, a former director, through an affiliated entity, Mak One LLP, as part of the 2023 Refinanced Notes ($29,926 thousand balance at 25.0% interest, due February 15, 2026) and 2023 New Notes ($7,283 thousand balance at 24.0% interest, due February 15, 2027).
• Mark Scatterday, through Mak One, was issued 45,539,951 Debt Modification Warrants in connection with the 2023 Refinanced Notes.

Stakeholder Impact

• Shareholders face significant dilution risk if the company pursues equity financing, and potential total loss of investment due to substantial doubt about going concern.
• Creditors (Note Holders) are impacted by the company's non-compliance with debt covenants and the ongoing negotiations, with high default interest rates reflecting increased risk.
• Employees may be affected by continued cost reduction strategies, including reduced headcount.
• Customers may experience changes in product availability or service as the company divests certain operations and navigates supply chain challenges.
• Suppliers, particularly Shenzhen Smoore Technology Limited, are impacted by the company's financial condition and the Smoore Agreements, which include a reduction plan for outstanding accounts payable.

Next Steps

• Increase revenue growth from existing and new products.
• Reduce production and operational costs through efficiencies or divestitures in cannabis operations.
• Reduce supply chain costs.
• Reduce and delay overhead and other certain expenditures.
• Obtain other financings or complete other strategic transactions as necessary.
• Defer principal and interest payments on notes payable.
• Negotiate with Note Holders to address non-compliance with payment obligations and covenants under the 2023 Refinanced Notes and 2023 New Notes.
• Complete the sale of Massachusetts dispensaries (Retail Disposal Group) within the next 12 months.
• Continue to manage and defend against multiple class-action antitrust lawsuits.

Key Dates

Recommendation

The company's financial position is highly distressed, marked by a 'going concern' warning, significant negative working capital, substantial revenue decline in key segments, and high default interest rates on its debt. While cost-cutting measures and IRS refunds provided some temporary cash flow relief, the fundamental business challenges, including ongoing litigation and the inability to meet debt covenants, present an extremely high risk profile. The potential for significant shareholder dilution from future capital raises, coupled with the requirement to use such proceeds to pay down existing debt, further diminishes the investment appeal. A seasoned investor would view the current situation as indicative of severe operational and financial instability, making the stock a strong sell.

Keywords

Cannabis, Vaporizer, SEC Filing, 10-Q, Financial Results, Liquidity, Going Concern, Debt, Antitrust Litigation, Discontinued Operations, Marijuana, Jupiter Research, Standard Farms, Commonwealth Alternative Care